DXM + MDA, serotonergic cathinones, and other serotonergic releasers

Group assessment

This PHI covers the named group; its members do not have separate PHI ratings.

PHI 7 to 9

https://dxm-atlas.org/en/interactions/mda-cathinones-serotonergic-releasers/

Compare

Key points for this combination

The group’s rating is based on extrapolation from the properties of its substances. The review separately discusses an MDMA study: its CYP2D6 findings concern MDMA and do not by themselves describe the other substances in this group.

General concepts in this text

CYP2D6

One of the CYP enzymes involved in processing drugs.

Inhibition means reducing enzyme activity; it can change the processing of drugs.

Sources: CYP2D6

Extrapolation

Using information from studied groups, conditions or products to draw conclusions about other groups, conditions or products.

This relies on assumptions about how the studied and new situations are related.

Sources: Extrapolation

How well is this understood?

Mechanism confidence: medium

Confidence in the mechanism: medium

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Confidence in human DXM data: low

Confidence in direct human evidence involving DXM: low

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method

How to read ratings and study limits

How do the substances interact?

How can the effects add up?

Mechanism: REL — Monoamine release
ⓘ

Neurotransmitter release

Movement of neurotransmitter molecules from a nerve ending into the space between cells.

During release a neurotransmitter leaves a nerve ending; during reuptake it returns into a cell.

Sources: Neurotransmitter release
Mechanism: SYM — Cardiovascular and thermal stress
ⓘ

Autonomic nervous system

The part of the nervous system that regulates the heart, internal organs and glands without conscious control of each response.

The sympathetic division is part of this system. In a response to threat it can increase heart rate and sweating.

Sources: Autonomic nervous system

Sources

Check the review’s wording

Class extrapolation; MDMA’s CYP2D6 effect cannot automatically be transferred to other substances

Combination row in the review: REL — Monoamine release; SYM — Cardiovascular and thermal stress

Related entries

Reference

Open the source and related combinations →